^
No biomarker
Hairy Cell Leukemia
cladribine
Sensitive
:
A1
No biomarker
Hairy Cell Leukemia
moxetumomab pasudotox
Sensitive
:
A1
No biomarker
Hairy Cell Leukemia
rituximab
Sensitive
:
A2
No biomarker
Hairy Cell Leukemia
rituximab
Sensitive
:
A2
No biomarker
Hairy Cell Leukemia
vemurafenib + rituximab
Sensitive
:
A2
No biomarker
Hairy Cell Leukemia
pentostatin
Sensitive
:
A2
No biomarker
Hairy Cell Leukemia
rituximab/hyaluronidase
Sensitive
:
A2
No biomarker
Hairy Cell Leukemia
rituximab
Sensitive
:
A2
No biomarker
Hairy Cell Leukemia
vemurafenib
Sensitive
:
A2
No biomarker
Hairy Cell Leukemia
ibrutinib
Sensitive
:
A2
BRAF V600E
Hairy Cell Leukemia
dabrafenib
Sensitive
:
C1
BRAF V600
Hairy Cell Leukemia
vemurafenib
Sensitive
:
C1
BRAF V600E
Hairy Cell Leukemia
vemurafenib
Sensitive
:
C1
BRAF V600E
Hairy Cell Leukemia
dabrafenib + rituximab
Sensitive
:
C3
MYD88 L265P + BRAF V600E
Hairy Cell Leukemia
rituximab
Sensitive
:
C4
KRAS mutation
Hairy Cell Leukemia
vemurafenib
Resistant
:
C4
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our